Logo
Please rotate your device

Landscape orientation recommended.

Menu

No results found.

ITRK
Intertek Group plc – LSE
Weekly Share Price & Valuation Overview
Market Overview
Open
4692.0000
Close
4648.0000
High
4692.0000
Low
4630.0000
Trend
0.35978

Intertek Group plc

United Kingdom • LSE - London Stock Exchange • ITRK • Currency: GBp

Intertek Group plc provides quality assurance solutions to various industries in the United Kingdom, the United States, China, Australia, and internationally. The company operates through five segments: Consumer Products, Corporate Assurance, Health and Safety, Industry and Infrastructure, and World of Energy. It offers quality assurance, testing, inspection, and certification services, including laboratory safety, quality and performance testing, accredited third-party management systems auditing and certification, technical inspection, second-party supplier auditing and supply chain solutions, sustainability data verification, process performance analysis and training, food safety testing, hygiene and safety audits, advisory and consulting, and validation services, as well as hardware, software, and cyber security solutions. The company also provides asset performance management, analytical testing, non-destructive and materials testing, engineering, cargo and inventory inspection, analytical assessment, calibration, supply-chain traceability, and related research and technical services, as well as support services in product development, regulatory authorization, chemical testing, and production. It serves a range of industries, including textiles, footwear, toys, hardlines, home appliances, consumer electronics, information and communication technology, automotive, aerospace, lighting, building products, industrial and renewable energy products, oil and gas, petrochemical, minerals, exploration, ore and mining, building and construction, solar energy, energy storage, green hydrogen, petroleum and biofuels, agricultural supply chain, food, transportation, chemicals and pharma, and healthcare, as well as governments, regulatory bodies, and exporters and importers to support trade compliance. The company was founded in 1885 and is based in London, the United Kingdom.

Key strengths
  • Healthy operating margin (≥15%) indicates efficient core operations.
  • Double-digit profit margin (≥10%) supports robust bottom-line economics.
  • ROE ≥15% reflects strong returns on shareholder equity.
  • ROA ≥7% shows efficient use of assets.
  • Earnings growth ≥10% supports improving profitability trajectory.
  • Quick ratio ≥1.0 indicates obligations can be met without inventory.
Scale & Structure Core size and share structure. TTM values unless noted. “Estimated” where reconciled from per-share × shares.
Market Cap Total equity value of the company (share price × shares outstanding).
GBp 7.28B
Enterprise Value Operating value: market cap + total debt − cash.
GBp 8.56B
Total Revenue (TTM) Sales over the last twelve months. May be estimated from revenue per share when inconsistent.
GBp 3.40B
Revenue per Share (TTM) Total revenue divided by shares outstanding (may be estimated).
GBp 21.16
EPS (TTM) Earnings per share over the last twelve months (may be estimated from net income ÷ shares).
2.24
Dividend Yield Annual dividend ÷ share price. Reconciled using dividend per share when available.
3.44%
Shares Outstanding
156.01M
Float Shares
156.53M
Implied Shares Outstanding
168.02M
Profitability & Efficiency TTM basis. “Reconciled” = numerator ÷ TTM revenue. Financials: EBITDA/Gross Profit may be hidden where not meaningful. EBITDA suppressed where implausible vs revenue.
Operating Margin (TTM) Strong Operating income ÷ revenue over the last twelve months (reconciled when possible).
15.49%
Profit Margin (TTM) Solid Net income ÷ revenue over the last twelve months (reconciled when possible).
10.66%
ROA Strong Return on assets: net income ÷ total assets.
9.85%
ROE Excellent Return on equity: net income ÷ shareholder equity.
30.30%
Growth Growth rates are YoY unless labeled QoQ.
Revenue Growth Year-over-year revenue growth.
0.20%
Earnings Growth (YoY) Strong Year-over-year earnings growth.
12.40%
Earnings Growth (QoQ) Quarter-over-quarter earnings growth.
11.70%
Liquidity & Solvency Balance-sheet health. Debt metrics shown as latest ratios; D/E is a ratio (not %).
Quick Ratio Adequate Liquid current assets ÷ current liabilities (ex-inventory).
1.31
Debt to Equity Total debt ÷ shareholder equity; leverage.
1.24
Total Cash Cash and equivalents.
GBp 365.30M
Total Debt Short + long-term interest-bearing debt.
GBp 1.45B
Net Debt Total debt − cash (negative = net cash).
GBp 1.08B
Sharemaestro House View
Confidence: 2 Sharemaestro internal conviction (0–3, higher is better). Risk: 1 Sharemaestro internal risk profile (0–3, higher is safer). Operational: 2 Operational quality/consistency (0–3, higher is better). Composite Score: 3 Overall internal composite (0–3, higher is better). Suggested Allocation: 5.00% Indicative portfolio weighting suggestion based on house view.
Structural Insights (experimental)
Ownership & Liquidity
Free Float Proportion of shares available for public trading.
Insiders Shares held by company insiders (officers, directors). 0.7%
Institutions Shares held by institutions (funds, pensions). 73.8%
Capital Structure
Potential Dilution Increase in share count if options/convertibles exercise.
7.7%
Net Debt Total debt − cash (negative = net cash).
GBp 1.08B
31.8% of revenue Net debt relative to revenue — debt load vs business scale.
Resilience Score 0–100 composite of liquidity, leverage and cash conversion; higher is better. If inputs are unavailable, we estimate using proxies (Net debt vs revenue, Cash-to-Debt). It is a guide, not a rating. 72
Methodology Notes
  • EBITDA & EBITDA margin suppressed (implausible vs revenue or not meaningful for financials).
  • Gross Profit hidden for financial institutions (often redundant with revenue).
As of: 2025-08-18 03:52

Disclaimer: Information is compiled from publicly available sources and is subject to errors and omissions. It is provided as a guide only and does not constitute investment advice. Please do your own research.

AI generated insights not available yet. Sign in to generate the snapshot.